GlucoTrack, Inc. (GCTK)

USD 0.15

(-1.21%)

Total Assets Summary of GlucoTrack, Inc.

  • GlucoTrack, Inc.'s latest annual total assets in 2023 was 4.9 Million USD , up 101.19% from previous year.
  • GlucoTrack, Inc.'s latest quarterly total assets in 2024 Q2 was 608 Thousand USD , down -72.16% from previous quarter.
  • GlucoTrack, Inc. reported annual total assets of 2.43 Million USD in 2022, down -61.09% from previous year.
  • GlucoTrack, Inc. reported annual total assets of 6.26 Million USD in 2021, down -40.93% from previous year.
  • GlucoTrack, Inc. reported quarterly total assets of 2.18 Million USD for 2024 Q1, down -55.47% from previous quarter.
  • GlucoTrack, Inc. reported quarterly total assets of 4.9 Million USD for 2023 Q4, down -31.83% from previous quarter.

Annual Total Assets Chart of GlucoTrack, Inc. (2023 - 2011)

Historical Annual Total Assets of GlucoTrack, Inc. (2023 - 2011)

Year Total Assets Total Assets Growth
2023 4.9 Million USD 101.19%
2022 2.43 Million USD -61.09%
2021 6.26 Million USD -40.93%
2020 10.6 Million USD 727.0%
2019 1.28 Million USD 86.35%
2018 688.18 Thousand USD -58.76%
2017 1.66 Million USD -32.18%
2016 2.46 Million USD 15.39%
2015 2.13 Million USD -66.41%
2014 6.34 Million USD 130.33%
2013 2.75 Million USD 238.36%
2012 814.57 Thousand USD -62.68%
2011 2.18 Million USD 0.0%

Peer Total Assets Comparison of GlucoTrack, Inc.

Name Total Assets Total Assets Difference
Akoya Biosciences, Inc. 180.36 Million USD 97.281%
AngioDynamics, Inc. 317.67 Million USD 98.456%
AtriCure, Inc. 613.93 Million USD 99.201%
Avinger, Inc. 13.77 Million USD 64.379%
Azenta, Inc. 2.88 Billion USD 99.83%
BioLife Solutions, Inc. 412.71 Million USD 98.812%
The Cooper Companies, Inc. 11.65 Billion USD 99.958%
Daxor Corporation 34.86 Million USD 85.933%
Ekso Bionics Holdings, Inc. 28.91 Million USD 83.038%
Femasys Inc. 27.75 Million USD 82.328%
Harvard Bioscience, Inc. 137.36 Million USD 96.429%
Hologic, Inc. 9.15 Billion USD 99.946%
ICU Medical, Inc. 4.37 Billion USD 99.888%
Intuitive Surgical, Inc. 15.44 Billion USD 99.968%
KORU Medical Systems, Inc. 28.46 Million USD 82.766%
LeMaitre Vascular, Inc. 346.77 Million USD 98.586%
Innovative Eyewear, Inc. 6.21 Million USD 21.126%
Innovative Eyewear, Inc. 6.21 Million USD 21.126%
Masimo Corporation 3.04 Billion USD 99.839%
Microbot Medical Inc. 8.32 Million USD 41.095%
Meihua International Medical Technologies Co., Ltd. 171.91 Million USD 97.147%
Merit Medical Systems, Inc. 2.32 Billion USD 99.789%
Nephros, Inc. 11.86 Million USD 58.646%
NovoCure Limited 1.14 Billion USD 99.572%
NEXGEL, Inc. 9.95 Million USD 50.728%
NEXGEL, Inc. 9.95 Million USD 50.728%
Singular Genomics Systems, Inc. 265.46 Million USD 98.152%
OraSure Technologies, Inc. 482.84 Million USD 98.984%
Pro-Dex, Inc. 54.21 Million USD 90.952%
Pulse Biosciences, Inc. 60.8 Million USD 91.933%
Predictive Oncology Inc. 14.41 Million USD 65.978%
Precision Optics Corporation, Inc. 16.91 Million USD 70.998%
QuidelOrtho Corporation 8.56 Billion USD 99.943%
Repligen Corporation 2.82 Billion USD 99.826%
Sanara MedTech Inc. 73.87 Million USD 93.36%
STAAR Surgical Company 488.69 Million USD 98.996%
Sharps Technology, Inc. 11.78 Million USD 58.394%
Utah Medical Products, Inc. 135.45 Million USD 96.379%
DENTSPLY SIRONA Inc. 7.37 Billion USD 99.933%
Jin Medical International Ltd. 32.9 Million USD 85.093%